Metabolomics

Dataset Information

0

GNPS - Serum metabolomics-based study of Alzheimer's disease and Mild cognitive impairment patients.


ABSTRACT: The study recruited 158 participants from the Greek Association of Alzheimer s Disease and Related Disorders (GAADRD) Day Centers between 2016 and 2021. The cohort included 45 individuals with Mild Cognitive Impairment (MCI), 91 with Alzheimer s Disease (AD), and 22 Healthy Controls (HC), diagnosed per DSM V criteria. Comprehensive medical, laboratory, and neuropsychological evaluations were performed to confirm diagnoses. The analysis was performed using a Waters Xevo G3 QToF Mass Spectrometer coupled with a Waters ACQUITY Premier UPLC. Separation was achieved using a Waters ACQUITY Premier HSS T3 column, with 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) as mobile phases.

INSTRUMENT(S): Xevo G3 QTof

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Helen Gika  

PROVIDER: MSV000096802 | GNPS | Wed Jan 08 06:18:00 GMT 2025

REPOSITORIES: GNPS

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-01-08 | MSV000096802 | MassIVE
2022-08-12 | PXD031560 | Pride
2024-07-12 | MTBLS10002 | MetaboLights
2022-07-28 | MSV000090004 | GNPS
2016-03-15 | PXD003176 | Pride
2020-11-20 | GSE122664 | GEO
2025-05-07 | PXD055049 | Pride
2014-09-08 | GSE60983 | GEO
2009-07-24 | E-GEOD-12240 | biostudies-arrayexpress
| PRJNA813024 | ENA